Feasibility of using pemetrexed as a salvage regimen in heavily pre-treated patients with ovarian cancer: A retrospective review

被引:1
|
作者
Dottino, Peter [1 ]
Dashkoff, Matthew [1 ]
Beddoe, Ann Marie [1 ]
机构
[1] Icahn Sch Med, Dept Obstet Gynecol & Reprod Sci, New York, NY 10029 USA
关键词
SURVIVAL;
D O I
10.4103/ijc.IJC_284_19
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:491 / 493
页数:3
相关论文
共 50 条
  • [21] Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
    Francesco Legge
    Amelia Paglia
    Marco D'Asta
    Gilda Fuoco
    Giovanni Scambia
    Gabriella Ferrandina
    BMC Cancer, 11
  • [22] Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients
    Legge, Francesco
    Paglia, Amelia
    D'Asta, Marco
    Fuoco, Gilda
    Scambia, Giovanni
    Ferrandina, Gabriella
    BMC CANCER, 2011, 11
  • [23] Second complete remission induced by cyclophosphamide plus bevacizumab in two patients with heavily pre-treated ovarian cancer
    Alfonso Sánchez-Muñoz
    José Miguel Jurado
    Elisabeth Pérez-Ruiz
    Emilio Alba
    Clinical and Translational Oncology, 2009, 11 : 329 - 331
  • [24] Second complete remission induced by cyclophosphamide plus bevacizumab in two patients with heavily pre-treated ovarian cancer
    Sanchez-Munoz, Alfonso
    Miguel Jurado, Jose
    Perez-Ruiz, Elisabeth
    Alba, Emilio
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (05): : 329 - 331
  • [25] Outcome of individualised chemotherapy in heavily pre-treated recurrent ovarian carcinoma
    Creel, IA
    Sharma, S
    Neale, MH
    Di Nicolantonio, F
    Knight, LA
    Lamont, A
    Kurbacher, CM
    JOURNAL OF PATHOLOGY, 2002, 198 : 18A - 18A
  • [26] TREATMENT WITH ERIBULIN (HALAVEN) IN HEAVILY PRE-TREATED PATIENTS WITH METASTATIC BREAST CANCER
    Lynge, M.
    Liposits, G. I.
    Linnet, S.
    Langkjer, S. T.
    BREAST, 2013, 22 : S43 - S43
  • [27] Treatment with eribulin (halaven) in heavily pre-treated patients with metastatic breast cancer
    Rasmussen, Maja Lynge
    Liposits, Gabor
    Yogendram, Subethini
    Jensen, Anders Bonde
    Linnet, Soren
    Langkjer, Sven Tyge
    ACTA ONCOLOGICA, 2014, 53 (09) : 1275 - +
  • [28] Feasibility and outcome of weekly carboplatin and paclitaxel in an unselected population of pre-treated patients with epithelial ovarian cancer
    Sim, S. H.
    Hall, G.
    Jackson, D. P.
    Alison, D. L.
    Perren, T. J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 461 - 461
  • [29] A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer
    Rischin, D
    Phillips, KA
    Friedlander, M
    Harnett, P
    Quinn, M
    Richardson, G
    Martin, A
    GYNECOLOGIC ONCOLOGY, 2004, 93 (02) : 417 - 421
  • [30] Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients
    Hutt, Daphna
    Bielorai, Bella
    Baturov, Bella
    Z'orbinski, Inna
    Ilin, Natalia
    Adam, Etai
    Itzhaki, Orit
    Besser, Michal J.
    Toren, Amos
    Jacoby, Elad
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (04)